Lipiodol-TACE With Idarubicin for Hepatocellular Carcinoma

Clinical trial NCT05280444 · UNKNOWN

Trial details

NCT number: NCT05280444
Sponsor: Zhongda Hospital
Status: UNKNOWN
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Hepatocellular Carcinoma

Start date: 2022-05-28
Primary completion: 2023-06-30
Enrollment: 216

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.